Konrad-Martin Dawn, Billings Curtis J, McMillan Garnett P, McDermott Daniel, Gordon Jane, Austin Donald, Dille Marilyn F
1Veterans Affairs (VA) Rehabilitation Research & Development Service (RR&D) National Center for Rehabilitative Auditory Research, VA Portland Healthcare System, Portland, Oregon, USA; 2Department of Otolaryngology/Head & Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA; and 3Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Ear Hear. 2016 May-Jun;37(3):e173-87. doi: 10.1097/AUD.0000000000000255.
(1) To characterize the influence of type 2 diabetes mellitus (DM) on cortical auditory-evoked potentials (CAEPs) separate from the effects of normal aging, and (2) to determine whether the disease-related effects are modified by insulin dependence.
A cross-sectional study was conducted in a large cohort of Veterans to investigate the relationships among type 2 DM, age, and CAEPs in randomly selected participants with (N = 108) and without (N = 114) the disease and who had no more than a moderate hearing loss. Participants with DM were classified as insulin-dependent (IDDM, N = 47) or noninsulin-dependent (NIDDM, N = 61). Other DM measures included concurrent serum glucose, HbA1c, and duration of disease. CAEPs were evoked using a passive homogeneous paradigm (single repeating stimulus) by suprathreshold tones presented to the right ear, left ear, or both ears. Outcome measures were adjusted for the pure-tone threshold average for frequencies of 0.5, 1, and 2 kHz and analyzed for differences in age effects between participant groups using multiple regression.
There is little variation across test ear conditions (left, right, binaural) on any CAEP peak in any of the groups. Among no-DM controls, P2 latency increases about 9 msec per decade of life. DM is associated with an additional delay in the P2 latency of 7 and 9 msec for the IDDM and NIDDM groups, respectively. Moreover, the slope of the function relating P2 latency with age is similar across participant groups and thus the DM effect appears constant across age. Effects on N1 latency are considerably weaker, with age effects of less than 4 msec per decade across all groups, and DM effects of only 2 (IDDM) or 3 msec (NIDDM). In the NIDDM group, the slope relating N1 latency to age is steeper relative to that observed for the no-DM group, providing some evidence of accelerated "aging" for this CAEP peak. DM does not substantially reduce N1-P2 amplitude and age relationships with N1-P2 amplitude are effectively absent. There is no association between pure-tone average at 0.5, 1, and 2 kHz and any aspect of CAEPs in this cohort.
In a large cohort of Veterans, we found that type 2 DM is associated with prolonged N1 and P2 latencies regardless of whether insulin is required to manage the disease and independent of peripheral hearing thresholds. The DM-related effects on CAEP latencies are threefold greater for P2 compared with N1, and there is little support that at the cortical level, IDDM participants had poorer responses compared with NIDDM participants, although their responses were more variable. Overall, these results indicate that DM is associated with slowed preattentive neural conduction. Moreover, the observed 7 to 9 msec P2 latency delay due to DM is substantial compared with normal age changes in P2, which are 9 msec per decade of life in this cohort. Results also suggest that whereas N1 latency changes with age are more pronounced among individuals with DM versus without DM, there was no evidence for more rapid aging of P2 among patients with DM. Thus, the damage responsible for the major DM-related differences may occur early in the DM disease process. These cross-sectional results should be verified using a longitudinal study design.
(1)描述2型糖尿病(DM)对皮质听觉诱发电位(CAEPs)的影响,以区分其与正常衰老的影响,(2)确定疾病相关影响是否因胰岛素依赖而改变。
在一大群退伍军人中进行了一项横断面研究,以调查2型糖尿病、年龄和CAEPs之间的关系。随机选择患有(N = 108)和未患有(N = 114)该疾病且听力损失不超过中度的参与者。患有DM的参与者被分为胰岛素依赖型(IDDM,N = 47)或非胰岛素依赖型(NIDDM,N = 61)。其他DM指标包括同时测定的血清葡萄糖、糖化血红蛋白(HbA1c)和病程。通过向右侧耳、左侧耳或双耳呈现阈上纯音,采用被动均匀范式(单次重复刺激)诱发CAEPs。对0.5、1和2 kHz频率的纯音阈值平均值进行调整后作为结果指标,并使用多元回归分析参与者组之间年龄效应的差异。
在任何组中,任何CAEP波峰在不同测试耳条件(左耳、右耳、双耳)下的变化都很小。在无DM对照组中,P2潜伏期每十年增加约9毫秒。DM与IDDM组和NIDDM组P2潜伏期分别额外延迟7毫秒和9毫秒相关。此外,各参与者组中P2潜伏期与年龄关系的函数斜率相似,因此DM效应在各年龄段似乎是恒定的。对N1潜伏期的影响要弱得多,所有组中年龄效应每十年小于4毫秒,DM效应仅为2毫秒(IDDM)或3毫秒(NIDDM)。在NIDDM组中,N1潜伏期与年龄关系的斜率相对于无DM组观察到的斜率更陡,为该CAEP波峰的加速“衰老”提供了一些证据。DM并未显著降低N1 - P2波幅,且年龄与N1 - P2波幅之间实际上不存在关联。在该队列中,0.5、1和2 kHz的纯音平均值与CAEPs任何方面均无关联。
在一大群退伍军人中,我们发现2型糖尿病与N1和P2潜伏期延长相关,无论疾病管理是否需要胰岛素,且与外周听力阈值无关。与DM相关的对CAEP潜伏期的影响,P2比N1大三倍,几乎没有证据表明在皮质水平上,IDDM参与者与NIDDM参与者相比反应更差,尽管他们的反应更具变异性。总体而言,这些结果表明DM与注意前神经传导减慢有关。此外,与该队列中每十年9毫秒的P2正常年龄变化相比,DM导致的7至9毫秒P2潜伏期延迟相当显著。结果还表明,虽然与无DM个体相比,DM个体中N1潜伏期随年龄的变化更明显,但没有证据表明DM患者中P2衰老更快。因此,导致DM相关主要差异的损伤可能在DM疾病过程早期就已发生。这些横断面结果应使用纵向研究设计进行验证。